Japanese pharmaceutical and regulatory environment

Drastic regulatory changes in Japan since 1997 have had a considerable impact on the way new medicines are developed. The regulatory authority itself has been transformed. Clinical trials are now performed according to international guidelines. Clinical data generated in one area are acceptable in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagata, Ryoichi, Raflzadeh-Kabe, Jean-David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2002
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181698/
https://www.ncbi.nlm.nih.gov/pubmed/22034129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181698/
https://www.ncbi.nlm.nih.gov/pubmed/22034129

Ejemplares similares